Welcome to #ASCO25 ! On behalf of the🚨OncoAlert Network—hello from Chicago! 🌆 🔗 Sign up the Newsletter: oncoalert.m-pages.com/nhMpwe/oncoale… WE ARE ALL OncoAlert 🚨 For 7 years, we've brought you real-time updates from the biggest oncology congresses. This year, we’re back with: 🔹

Top Experts will Join COR2ED at #ASCO25 for Rapid Video Insights on Late-Breaking Data, stay tuned for some Great Insights LINK: buff.ly/He9wEAY In a series of short videos coming soon, Prof. Gerhardt Attard, first author on the AMPLITUDE study, will share

Coming soon: a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE study, Prof. Mark Socinski discussing insights on oncogene-addicted NSCLC, and Dr. Lizzy Smyth highlighting key gastric cancer updates.

🚨#ObGyn update from #ASCO25 🚨 Key #GynecologicalCancer insights presented by Prof. Domenica Loruss Featuring data from: - ENGOT-cx11/GOG-3047/KEYNOTE-A18 - ROSELLA - FIRST/ENGOT-OV44 - TRUST Will new data from ASCO impact clinical practice? Watch to find out! 📺 See more

🔎 In #EndometrialCancer, molecular classification is crucial not only for prognosis but also for guiding personalised treatment decisions Prof. Xavier Matias-Guiu G & Dr Jurjees Hasan explain more in this video podcast 📺 Listen on Apple/Spotify 👉 cor2ed.com/obstetrics-gyn… This

Join Leading Experts & COR2ED for Rapid Video Insights on Groundbreaking Data out of #ASCO25 LINK: buff.ly/He9wEAY Coming soon: a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE

Join Leading Experts & COR2ED for Rapid Video Insights on Groundbreaking Data out of #ASCO25 LINK: buff.ly/He9wEAY a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE study, Prof.

We are proud to collaborate with ICAN (ICAN, International Cancer Advocacy Network), a patient advocacy group that focuses on personalised cancer care programmes, health IT, legislation, and research. Learn more here: askican.org Find many of our ICAN-endorsed programmes here:

Join Leading Experts & COR2ED for Rapid Video Insights on Groundbreaking Data out of #ASCO25 LINK: buff.ly/He9wEAY a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE study, Prof.

Many women with postpartum haemorrhage (PPH) have no identifiable risk factors. Each year, 14 million women experience PPH, leading to 70,000 maternal deaths worldwide. Drs. Ahmadzia and Zdanowicz discuss how to ensure rapid access to treatment and support for your patients in

Catch up on highlights from #ASCO25! Experts joined us at ASCO to share their insights on how the latest data could change clinical practice ➡️ Prof. Mark Socinski: #NSCLC (downloadable slides also available) ➡️ Dr AttardLab: #ProstateCancer ➡️ Dr Lizzy Smyth: #GastricCancer

🧬 What do HCPs need to know about current treatment options for advanced/recurrent #EndometrialCancer? An animated #MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to

Catch this ESMO Virtual Plenary 2025 update on the latest TROPION-Breast01 study with Prof. François-Clément Bidard & Dr Barbara Pistilli This study evaluates datopotamab deruxtecan (Dato-DXd) versus chemotherapy in previously treated, inoperable or metastatic HR+/HER2– breast

➡️Advanced #endometrialcarcinoma video podcast Prof. Xavier Matias-Guiu G & Dr Jurjees Hasan discuss: - Molecular classification & treatment decisions - Trial data - Shared decision-making 📺 Watch the video below Listen on all podcast platforms / get the transcript 👉

🎉 COR2ED has over 12k subscribers on YouTube! 🎉 Do you follow us? ▶️youtube.com/@cor2edthehear… Join over 12k HCPs on our YouTube channel and stay up to date with #MedEd videos as they’re released 🎓 #MedicalEducation #Oncology #OBGYN

🧬 What do HCPs need to know about current treatment options for advanced/recurrent EndometrialCancer? An animated MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to

Advanced or recurrent endometrial cancer: Molecular classification & treatment decisions Medical experts Prof. Xavier Matias-Guiu G & Dr Jurjees Hasan explain the impact of molecular subtypes in treatment decisions in this video podcast 📺 Watch the video below Listen on all podcast